Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists seek better way to collect poop for microbiome studies

NCT ID NCT07452965

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find the best way to collect and handle stool samples for gut bacteria (microbiota) research. Researchers will compare different collection methods to the standard quick-freeze technique. Ten healthy adults aged 18 to 85 will provide samples. The goal is to improve accuracy in future microbiome studies, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and/or female * Age between 18 and 85 years * No diagnosed pathology * Not opposed to following the study procedures Exclusion Criteria: * Ongoing digestive neoplasia or \< 5 years * Digestive surgery with intestinal resection * Presence of inflammatory bowel disease or other familial gastrointestinal pathology * Chronic use of laxatives * Use of antibiotics in the two months prior to inclusion * Life-threatening conditions in the short term (progressive cancer, unstable heart failure, severe liver, kidney or respiratory failure) * Chronic psychosis or psychotic episodes * Alcohol or drug addiction * Epilepsy and other non-degenerative diseases of the central nervous system * Vitamin B12 and folic acid deficiency not supplemented * Untreated hypothyroidism * Pregnant or breastfeeding woman * Person deprived of liberty by judicial or administrative decision * Major protected by law * Not affiliated with a social security scheme or beneficiary of such a scheme * Having a period of relative exclusion in relation to another protocol * Having refused to participate in the protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Montpellier

    Montpellier, France, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.